Great West Life Assurance CO Fibrogen Inc Transaction History

Great West Life Assurance CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$2.49 - $20.59 $13,428 - $111,041	5,393 Added 27.76%	24,822 $67,000
Q1 2023 May 12, 2023	BUY	$15.95 - $25.18 $240,860 - $380,243	15,101 Added 348.91%	19,429 $363,000
Q4 2022 Feb 10, 2023	SELL	$13.27 - $17.73 $159,744 - $213,433	-12,038 Reduced 73.55%	4,328 $70,000
Q3 2022 Nov 01, 2022	BUY	$11.4 - $14.6 $186,572 - $238,943	16,366 New	16,366 $212,000
Q2 2021 Aug 11, 2021	SELL	$18.57 - $35.68 $21,429 - $41,174	-1,154 Reduced 21.05%	4,328 $115,000
Q3 2020 Nov 17, 2020	BUY	$40.47 - $45.5 $211,739 - $238,056	5,232 Added 2092.8%	5,482 $225,000
Q3 2020 Nov 13, 2020	SELL	$40.47 - $45.5 $211,739 - $238,056	-5,232 Reduced 95.44%	250 $10,000
Q4 2019 Feb 11, 2020	BUY	$34.58 - $48.06 $189,567 - $263,464	5,482 New	5,482 $235,000
Q3 2019 Oct 25, 2019	SELL	$36.98 - $48.45 $338,662 - $443,705	-9,158 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$35.13 - $55.53 $62,426 - $98,676	-1,777 Reduced 16.25%	9,158 $0
Q1 2019 May 08, 2019	BUY	$42.83 - $59.91 $95,982 - $134,258	2,241 Added 25.78%	10,935 $593,000
Q3 2017 Nov 09, 2017	BUY	$33.4 - $53.9 $290,379 - $468,606	8,694	8,694 $463,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $54.4M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.